Showing results (241-250 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|January 23, 2026
Content Validity of Two Generic Preference-Based Measures in Retinitis Pigmentosa, Including X-Linked Retinitis PigmentosaLouis S Matza, Timothy A Howell, Qiaoyi Zhang, et al.
Pharmacoeconomics - Open|January 6, 2026
Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 TrialAlice Hurrell, Louise Webster, Jenie Sparkes, et al.
Pharmacoeconomics - Open|October 23, 2025
The Consistency and Transferability of Economic Evaluations of Disease-Modifying Treatments for Multiple Sclerosis: Analysis of Cost-Effectiveness Assessments from Australia, England, Canada and ScotlandXiang Wang, Feili Zhao, David Newby, et al.
Pharmacoeconomics - Open|October 8, 2025
The Economic and Clinical Impact of Recurring Automated Red Blood Cell Exchange to Manage Sickle Cell Disease in the UKSarah M Medland, Jamie Bainbridge, Matthew Cawson, et al.
Pharmacoeconomics - Open|September 15, 2021
Patient and Caregiver Health State Utilities in Tuberous Sclerosis ComplexSiu Hing Lo, Jade Marshall, Hanna Skrobanski, et al.
Pharmacoeconomics - Open|August 5, 2025
Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated PatientsSilvia Fenix-Caballero, Pablo Caleffa-Menendez, Carmen Maria Dominguez-Santana, et al.
Pharmacoeconomics - Open|September 9, 2025
Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in ChinaLulu Liu, Qilin Zhang, Yamin Shu, et al.
Pharmacoeconomics - Open|September 26, 2025
Estimating the Value of Adding 30 Days to the 180-Day Market Exclusivity of the First-to-File Generic Drug ManufacturerAylin Sertkaya, Zeid El-Kilani, Sean Klein, et al.
Pharmacoeconomics - Open|August 14, 2021
Cost Effectiveness of a Cultural Physical Activity Intervention to Reduce Blood Pressure Among Native Hawaiians with HypertensionAshley F Railey, Clemma Muller, Carolyn Noonan, et al.
Pharmacoeconomics - Open|August 10, 2021
Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in JapanTomoyuki Takura, Akira Yuasa, Naohiro Yonemoto, et al.
Pageof 61